https://www.instituteatprecision.com/experts/hannah-deresiewicz2026-06-29https://www.instituteatprecision.com/insights/phase-iii-apachttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/APAC-NRDL-LP-Card-1.svgAPAC-NRDL-LP-Card-1APAC-NRDL-LP-Card-1https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/About-page-card-3-opt-2.svgAbout-page-card-3-opt-2About-page-card-3-opt-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/About-page-card-2-gold.svgAbout-page-card-2-goldAbout-page-card-2-goldhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aq2026-06-30https://www.instituteatprecision.com/experts/sean-hart2026-06-29https://www.instituteatprecision.com/experts/isabella-sergio2026-06-29https://www.instituteatprecision.com/experts/angelica-norrell2026-06-29https://www.instituteatprecision.com/experts/ross-maclean2026-06-29https://www.instituteatprecision.com/experts/travis-harrison2026-06-29https://www.instituteatprecision.com/experts/lance-grady2026-06-29https://www.instituteatprecision.com/experts/christopher-terrone2026-06-29https://www.instituteatprecision.com/experts/jeroen-jansen2026-06-29https://www.instituteatprecision.com/insights/apac-nrdlhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/APAC-NRDL-LP-Card-1.svgAPAC-NRDL-LP-Card-1APAC-NRDL-LP-Card-1https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/APAC-NRDL-LP-Card-2.svgAPAC-NRDL-LP-Card-2APAC-NRDL-LP-Card-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/APAC-NRDL-LP-Card-3.svgAPAC-NRDL-LP-Card-3APAC-NRDL-LP-Card-3https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicine2026-06-30https://www.instituteatprecision.com/experts/angelina-bisconte2026-06-29https://www.instituteatprecision.com/radiopharmaceuticalshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Kurt%20Preugschat.pngKurt PreugschatKurt Preugschathttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Nicholas%20Richardson.pngNicholas RichardsonNicholas Richardsonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/radiopharm-topic-page-card-1-opt2.webpradiopharm-topic-page-card-1-opt2radiopharm-topic-page-card-1-opt2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Stephanie%20Kennedy.pngStephanie KennedyStephanie Kennedyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Angelica%20Norrell.pngAngelica NorrellAngelica Norrellhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Julianna%20Kula.pngJulianna KulaJulianna Kulahttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Cherry%20Moldovan.pngCherry MoldovanCherry Moldovanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Greg%20Gregory.pngGreg GregoryGreg Gregoryhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Hannah%20Deresewicz.pngHannah DeresewiczHannah Deresewiczhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/radiopharm-topic-page-card-2.webpradiopharm-topic-page-card-2radiopharm-topic-page-card-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Wall%20Street%20Perspective%20on%20Radiopharmaceuticals.jpgWall Street Perspective on RadiopharmaceuticalsWall Street Perspective on Radiopharmaceuticalshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Advancing%20Radiopharmaceuticals%20From%20Regulatory%20Approval%20to%20Global%20Access.jpgAdvancing Radiopharmaceuticals From Regulatory Approval to Global AccessAdvancing Radiopharmaceuticals From Regulatory Approval to Global Accesshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/John%20McIntyre.pngJohn McIntyreJohn McIntyrehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ivan%20Barrera.pngIvan BarreraIvan Barrerahttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Challenges%20and%20Opportunities%20for%20Radiopharmaceutical%20Commercialization.jpgChallenges and Opportunities for Radiopharmaceutical CommercializationChallenges and Opportunities for Radiopharmaceutical Commercializationhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/radiopharm-topic-page-card3.webpradiopharm-topic-page-card3radiopharm-topic-page-card3https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Bob%20Bauer.pngBob BauerBob Bauerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Anne%20Marie%20Fields.pngAnne Marie FieldsAnne Marie Fieldshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Geoffrey%20Kannan.pngGeoffrey KannanGeoffrey Kannanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jing%20Ping%20Yeo.pngJing Ping YeoJing Ping Yeohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Harpreet%20Singh.pngHarpreet SinghHarpreet Singhhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Andrew%20Dymon.pngAndrew DymonAndrew Dymonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Managing%20Operational%20Complexity%20in%20Early-Phase%20Oncology%20Radiopharmaceutical%20Trials.jpgManaging Operational Complexity in Early-Phase Oncology Radiopharmaceutical TrialsManaging Operational Complexity in Early-Phase Oncology Radiopharmaceutical Trialshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Navigating%20Global%20Regulations%20for%20Radiopharmaceutical%20Development.jpgNavigating Global Regulations for Radiopharmaceutical DevelopmentNavigating Global Regulations for Radiopharmaceutical Development2026-06-30https://www.instituteatprecision.com/experts/ruby-wang2026-06-29https://www.instituteatprecision.com/experts/nate-wible2026-06-29https://www.instituteatprecision.com/insightshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Improving%20Patient%20Access%20to%20Cell%20Therapy%20Through%20Decentralized%20Manufacturing.jpgImproving Patient Access to Cell Therapy Through Decentralized ManufacturingImproving Patient Access to Cell Therapy Through Decentralized Manufacturinghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Characterized%20Biospecimens_%20A%20Guide%20for%20Leveraging%20Deeply%20Characterized%20Biospecimens%20to%20Support%20Successful%20Therapeutic%20&%20Diagnostic%20Development.jpgCharacterized Biospecimens_ A Guide for Leveraging Deeply Characterized Biospecimens to Support Successful Therapeutic & Diagnostic DevelopmentCharacterized Biospecimens_ A Guide for Leveraging Deeply Characterized Biospecimens to Support Successful Therapeutic & Diagnostic Developmenthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Methods%20for%20Incorporating%20Non-Randomized%20Evidence%20From%20Single-Arm%20Trials%20Into%20Network%20Meta-Analysis%20(NMA).jpgMethods for Incorporating Non-Randomized Evidence From Single-Arm Trials Into Network Meta-Analysis (NMA)Methods for Incorporating Non-Randomized Evidence From Single-Arm Trials Into Network Meta-Analysis (NMA)https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Innovation%2c%20Personalization%20&%20the%20Future%20of%20Oncology_%20How%20AI%20Is%20Transforming%20Cancer%20Care.jpgInnovation, Personalization & the Future of Oncology_ How AI Is Transforming Cancer CareInnovation, Personalization & the Future of Oncology_ How AI Is Transforming Cancer Carehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Why%20Antibody-Drug%20Conjugates%20Are%20Revolutionizing%20Precision%20Oncology.jpgWhy Antibody-Drug Conjugates Are Revolutionizing Precision OncologyWhy Antibody-Drug Conjugates Are Revolutionizing Precision Oncologyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Clinical%20Trial%20Trends_%20Antibody-Drug%20Conjugates.jpgClinical Trial Trends_ Antibody-Drug ConjugatesClinical Trial Trends_ Antibody-Drug Conjugateshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Can%20Distributional%20Cost%20Effectiveness%20Analysis%20Actually%20Inform%20On%20and%20Improve%20Health%20Equity%20in%20Oncology_.jpgCan Distributional Cost Effectiveness Analysis Actually Inform On and Improve Health Equity in Oncology_Can Distributional Cost Effectiveness Analysis Actually Inform On and Improve Health Equity in Oncology_https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/FDA%20Accelerated%20Approval%20for%20Oncology.jpgFDA Accelerated Approval for OncologyFDA Accelerated Approval for Oncologyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Payors%2c%20Pharma%20Engage%20Alternative%20Payment%20Models%20Amid%20High%20Gene%20Therapy%20Cost%2c%20Efficacy%20Unknowns.jpgPayors, Pharma Engage Alternative Payment Models Amid High Gene Therapy Cost, Efficacy UnknownsPayors, Pharma Engage Alternative Payment Models Amid High Gene Therapy Cost, Efficacy Unknownshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Clinical%20Outcomes%20of%20PD-1_PD-L1%20Inhibitors%20Among%20Patients%20With%20Advanced%20or%20Metastatic%20Non-Small%20Cell%20Lung%20Cancer.jpgClinical Outcomes of PD-1_PD-L1 Inhibitors Among Patients With Advanced or Metastatic Non-Small Cell Lung CancerClinical Outcomes of PD-1_PD-L1 Inhibitors Among Patients With Advanced or Metastatic Non-Small Cell Lung Cancerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Why%20Cardiovascular-Kidney-Metabolic%20Health%20Is%20a%20Priority%20for%20Payers%20&%20What%20It%20Means%20for%20Manufacturers.jpgWhy Cardiovascular-Kidney-Metabolic Health Is a Priority for Payers & What It Means for ManufacturersWhy Cardiovascular-Kidney-Metabolic Health Is a Priority for Payers & What It Means for Manufacturershttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/CGT%20Is%20In%20Its%20Infancy%20For%20CNS%20Disorders%2c%20But%20Technical%20Strides%20Being%20Made.jpgCGT Is In Its Infancy For CNS Disorders, But Technical Strides Being MadeCGT Is In Its Infancy For CNS Disorders, But Technical Strides Being Madehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20ADC%20Pendulum.webpThe ADC PendulumThe ADC Pendulumhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Are%20Rare%20Brain%20Diseases%20the%20Next%20Commercial%20Frontier%20for%20Gene%20Therapy_.jpgAre Rare Brain Diseases the Next Commercial Frontier for Gene Therapy_Are Rare Brain Diseases the Next Commercial Frontier for Gene Therapy_https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Securing%20Access%20&%20Reimbursement%20for%20Rare%20Disease%20Therapies.jpgSecuring Access & Reimbursement for Rare Disease TherapiesSecuring Access & Reimbursement for Rare Disease Therapieshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Cohort%20Management_%20Best%20Practices%20for%20Early%20Phase%20Oncology%20Clinical%20Trials.jpgCohort Management_ Best Practices for Early Phase Oncology Clinical TrialsCohort Management_ Best Practices for Early Phase Oncology Clinical Trialshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Navigating%20Global%20Regulations%20for%20Radiopharmaceutical%20Development.jpgNavigating Global Regulations for Radiopharmaceutical DevelopmentNavigating Global Regulations for Radiopharmaceutical Developmenthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Leveraging%20Early%20Access_Compassionate%20Use%20Pathways%20to%20Provide%20Market-Specific%20Real-World%20Evidence%20Before%20Launch.jpgLeveraging Early Access_Compassionate Use Pathways to Provide Market-Specific Real-World Evidence Before LaunchLeveraging Early Access_Compassionate Use Pathways to Provide Market-Specific Real-World Evidence Before Launchhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Validation%20of%20an%20IFN-y%20ELISpot%20Assay%20for%20Measuring%20T-Cell%20Responses%20Against%20Viral%20Antigens%2c%20in%20AAV-based%20Gene%20Ther.jpgValidation of an IFN-y ELISpot Assay for Measuring T-Cell Responses Against Viral Antigens, in AAV-based Gene TherValidation of an IFN-y ELISpot Assay for Measuring T-Cell Responses Against Viral Antigens, in AAV-based Gene Therhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Immune%20Cell%20Profiling%20in%20Translational%20Research.jpgImmune Cell Profiling in Translational ResearchImmune Cell Profiling in Translational Researchhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Guide%20to%20Successfully%20Conducting%20Tissue%20Cross-Reactivity%20Studies.jpgGuide to Successfully Conducting Tissue Cross-Reactivity StudiesGuide to Successfully Conducting Tissue Cross-Reactivity Studieshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/AI-powered%20real-world%20evidence%20generation%20for%20biotechs.jpgAI-powered real-world evidence generation for biotechsAI-powered real-world evidence generation for biotechshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Innovation%20and%20Challenges%20in%20Cell%20&%20Gene%20Therapy.jpgInnovation and Challenges in Cell & Gene TherapyInnovation and Challenges in Cell & Gene Therapyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Exploring%20Decision-makers%20Challenges%20and%20Strategies%20When%20Selecting%20Multiple%20Systematic%20Reviews.jpgExploring Decision-makers Challenges and Strategies When Selecting Multiple Systematic ReviewsExploring Decision-makers Challenges and Strategies When Selecting Multiple Systematic Reviewshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Optimizing%20Successful%20Gene%20Therapy%20Development.jpgOptimizing Successful Gene Therapy DevelopmentOptimizing Successful Gene Therapy Developmenthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Challenges%20and%20Opportunities%20for%20Radiopharmaceutical%20Commercialization.jpgChallenges and Opportunities for Radiopharmaceutical CommercializationChallenges and Opportunities for Radiopharmaceutical Commercializationhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Managing%20Operational%20Complexity%20in%20Early-Phase%20Oncology%20Radiopharmaceutical%20Trials.jpgManaging Operational Complexity in Early-Phase Oncology Radiopharmaceutical TrialsManaging Operational Complexity in Early-Phase Oncology Radiopharmaceutical Trialshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Phase%203%20Prostate%20Cancer%20Case%20Study_%20Radiopharm%20Imaging%20at%20Scale.jpgPhase 3 Prostate Cancer Case Study_ Radiopharm Imaging at ScalePhase 3 Prostate Cancer Case Study_ Radiopharm Imaging at Scalehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Journey%20of%20a%20Therapeutic%20Antibody_%20From%20Preclinical%20to%20Clinical%20Proof%20of%20Concept%20Development.jpgJourney of a Therapeutic Antibody_ From Preclinical to Clinical Proof of Concept DevelopmentJourney of a Therapeutic Antibody_ From Preclinical to Clinical Proof of Concept Developmenthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Advancing%20Radiopharmaceuticals%20From%20Regulatory%20Approval%20to%20Global%20Access.jpgAdvancing Radiopharmaceuticals From Regulatory Approval to Global AccessAdvancing Radiopharmaceuticals From Regulatory Approval to Global Accesshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Quantitative%20Multiplex%20Immunofluorescence%20_%20A%20Powerful%20Tool%20for%20Oncology%20Therapeutic%20Development.jpgQuantitative Multiplex Immunofluorescence _ A Powerful Tool for Oncology Therapeutic DevelopmentQuantitative Multiplex Immunofluorescence _ A Powerful Tool for Oncology Therapeutic Developmenthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Twenty-Five%20Years%20of%20Antibody%E2%80%93Drug%20Conjugates_%20From%20Breakthroughs%20to%20Access%20by%20Design.jpgTwenty-Five Years of Antibody–Drug Conjugates_ From Breakthroughs to Access by DesignTwenty-Five Years of Antibody–Drug Conjugates_ From Breakthroughs to Access by Designhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Pros%20and%20Cons%20of%20Various%20Reimbursement%20Models%20for%20Cell%20and%20Gene%20Therapies.jpgPros and Cons of Various Reimbursement Models for Cell and Gene TherapiesPros and Cons of Various Reimbursement Models for Cell and Gene Therapieshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/How%20Health%20Systems%20Are%20Using%20AI%20In%20Clinical%20Decision-Making.jpgHow Health Systems Are Using AI In Clinical Decision-MakingHow Health Systems Are Using AI In Clinical Decision-Makinghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Breaking%20Through%20in%20Hematologic%20Malignancies.jpgBreaking Through in Hematologic MalignanciesBreaking Through in Hematologic Malignancieshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20Role%20of%20Societal%20Value%20Analyses%20in%20Supporting%20Access%20to%20Novel%20Pharmacotherapies%20in%20Asia-Pacific%20Markets.jpgThe Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific MarketsThe Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific Marketshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Understanding%20Immunogenicity%20and%20AAV%20Gene%20Therapy.jpgUnderstanding Immunogenicity and AAV Gene TherapyUnderstanding Immunogenicity and AAV Gene Therapyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Pembrolizumab%20Plus%20Chemotherapy%20For%20First-line%20Treatment%20Of%20Advanced%20Triple-negative%20Breast%20Cancer.jpgPembrolizumab Plus Chemotherapy For First-line Treatment Of Advanced Triple-negative Breast CancerPembrolizumab Plus Chemotherapy For First-line Treatment Of Advanced Triple-negative Breast Cancerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Shifting%20Oncology%20Management%20Strategies%20Among%20Payers%20and%20Providers.jpgShifting Oncology Management Strategies Among Payers and ProvidersShifting Oncology Management Strategies Among Payers and Providershttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20APAC%20Imperative%20for%20Phase%20III%20Trials.jpgThe APAC Imperative for Phase III TrialsThe APAC Imperative for Phase III Trialshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Exploring%20the%20Intricacies%20of%20the%20Immune%20System_%20A%20Practical%20Guide.jpgExploring the Intricacies of the Immune System_ A Practical GuideExploring the Intricacies of the Immune System_ A Practical Guidehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Navigating%20340B%20and%20Rebates_%20Challenges%2c%20Solutions%2c%20and%20the%20Path%20Forward.jpgNavigating 340B and Rebates_ Challenges, Solutions, and the Path ForwardNavigating 340B and Rebates_ Challenges, Solutions, and the Path Forwardhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Moving%20ADCs%20to%20the%20Front%20Line_%20Perspectives%20from%20FDA%20Oncology%20Experts.jpgMoving ADCs to the Front Line_ Perspectives from FDA Oncology ExpertsMoving ADCs to the Front Line_ Perspectives from FDA Oncology Expertshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/How%20to%20align%20Pricing%20&%20Contracting%20with%20Stakeholder%20Needs.jpgHow to align Pricing & Contracting with Stakeholder NeedsHow to align Pricing & Contracting with Stakeholder Needshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Wall%20Street%20Perspective%20on%20Radiopharmaceuticals.jpgWall Street Perspective on RadiopharmaceuticalsWall Street Perspective on Radiopharmaceuticalshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Market%20Outlook%20Q4%202025_%20Antibody-Drug%20Conjugates%20(ADCs).jpgMarket Outlook Q4 2025_ Antibody-Drug Conjugates (ADCs)Market Outlook Q4 2025_ Antibody-Drug Conjugates (ADCs)https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Designing%20Seamless%20Phase%201_2%20Oncology%20Trials.jpgDesigning Seamless Phase 1_2 Oncology TrialsDesigning Seamless Phase 1_2 Oncology Trialshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/PD-L1%20Expression%20on%20Immune%20Cells%20from%20Solid%20Tumor%20Patients_%20Implications%20for%20Tumor%20Immunity%20and%20Immunotherapy.jpgPD-L1 Expression on Immune Cells from Solid Tumor Patients_ Implications for Tumor Immunity and ImmunotherapyPD-L1 Expression on Immune Cells from Solid Tumor Patients_ Implications for Tumor Immunity and Immunotherapyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Utilization%20of%20Multiparameter%20Flow%20Cytometry%20for%20Immune%20Monitoring%20of%20Tumor%20Infiltrating%20Lymphocytes%20Isolated%20from.jpgUtilization of Multiparameter Flow Cytometry for Immune Monitoring of Tumor Infiltrating Lymphocytes Isolated fromUtilization of Multiparameter Flow Cytometry for Immune Monitoring of Tumor Infiltrating Lymphocytes Isolated fromhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Caregiving%20in%20Alzheimer%CE%93%C3%87%C3%96s%20and%20Related%20Dementias_%20Finding%20Opportunities%20to%20Optimize%20Caregiver%20Support.jpgCaregiving in AlzheimerΓÇÖs and Related Dementias_ Finding Opportunities to Optimize Caregiver SupportCaregiving in AlzheimerΓÇÖs and Related Dementias_ Finding Opportunities to Optimize Caregiver Supporthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20Role%20of%20Pharmaceutical%20Innovation%20in%20Clinical%20Practice%20Guidelines%20for%20Chronic%20Diseases.jpgThe Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic DiseasesThe Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseaseshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Evolutions%20in%20Oncology%20Cell%20Therapy.jpgEvolutions in Oncology Cell TherapyEvolutions in Oncology Cell Therapyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Payer%20Challenges%20for%20Patient%20Access%20to%20Autologous%20Cell%20and%20Gene%20Therapies.jpgPayer Challenges for Patient Access to Autologous Cell and Gene TherapiesPayer Challenges for Patient Access to Autologous Cell and Gene Therapieshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/HEOR%20Value%20demonstration%20for%20Antibody-Drug%20Conjugates_%20Lessons%20learned%20from%20the%20first%2025%20years.jpgHEOR Value demonstration for Antibody-Drug Conjugates_ Lessons learned from the first 25 yearsHEOR Value demonstration for Antibody-Drug Conjugates_ Lessons learned from the first 25 yearshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/China%20Market%20Access%20After%20NRDL%20Maturity-What%20Comes%20After%20the%20Price%20Reset.jpgChina Market Access After NRDL Maturity-What Comes After the Price ResetChina Market Access After NRDL Maturity-What Comes After the Price Resethttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Architecting%20the%20Future%20Of%20Prior%20Authorization_%20A%20Blueprint%20for%20Scalable%20Automation%20Under%20The%20CMS%20Interoperability.jpgArchitecting the Future Of Prior Authorization_ A Blueprint for Scalable Automation Under The CMS InteroperabilityArchitecting the Future Of Prior Authorization_ A Blueprint for Scalable Automation Under The CMS Interoperabilityhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Validation%20of%20an%20approach%20to%20measure%20high%20levels%20of%20neutralizing%20antibodies%20against%20AAV%20in%20human%20serum%20samples.jpgValidation of an approach to measure high levels of neutralizing antibodies against AAV in human serum samplesValidation of an approach to measure high levels of neutralizing antibodies against AAV in human serum samples2026-06-29https://www.instituteatprecision.com/experts/kyle-sarnataro2026-06-29https://www.instituteatprecision.com/experts/greg-gregory2026-06-29https://www.instituteatprecision.com/contacthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precision2026-06-29https://www.instituteatprecision.com/experts/andrew-cournoyer2026-06-29https://www.instituteatprecision.com/experts/jacki-chou2026-06-29https://www.instituteatprecision.com/experts/nicholas-richardson2026-06-29https://www.instituteatprecision.com/experts/molly-borchardt2026-06-29https://www.instituteatprecision.com/experts/chloe-wang2026-06-29https://www.instituteatprecision.com/apachttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ross%20Maclean.pngRoss MacleanRoss Macleanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Chloe%20Wang.jpgChloe WangChloe Wanghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20APAC%20Imperative%20for%20Phase%20III%20Trials.jpgThe APAC Imperative for Phase III TrialsThe APAC Imperative for Phase III Trialshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Sean%20Hart.pngSean HartSean Harthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Cherry%20Moldovan.pngCherry MoldovanCherry Moldovanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20Role%20of%20Societal%20Value%20Analyses%20in%20Supporting%20Access%20to%20Novel%20Pharmacotherapies%20in%20Asia-Pacific%20Markets.jpgThe Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific MarketsThe Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific Marketshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Zhenfei%20Yin.pngZhenfei YinZhenfei Yinhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/AQ_GlobalAccess_AlexGrosvenor-2.jpgAQ_GlobalAccess_AlexGrosvenor-2AQ_GlobalAccess_AlexGrosvenor-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ruby%20Wang.jpgRuby WangRuby Wanghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Jacki%20Chou.pngJacki ChouJacki Chouhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jing%20Ping%20Yeo.pngJing Ping YeoJing Ping Yeohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Marlon%20Graf.jpgMarlon GrafMarlon Grafhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/China%20Market%20Access%20After%20NRDL%20Maturity-What%20Comes%20After%20the%20Price%20Reset.jpgChina Market Access After NRDL Maturity-What Comes After the Price ResetChina Market Access After NRDL Maturity-What Comes After the Price Resethttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/James%20Cheong%20(1).pngJames Cheong (1)James Cheong (1)https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicine2026-06-30https://www.instituteatprecision.com/experts/andrew-dymon2026-06-29https://www.instituteatprecision.com/experts/harpreet-singh2026-06-29https://www.instituteatprecision.com/experts/jen-vance2026-06-29https://www.instituteatprecision.com/experts/geoffrey-kannan2026-06-29https://www.instituteatprecision.comhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/radiopharm-topic-card.webpradiopharm-topic-cardradiopharm-topic-cardhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/adcs-topic-card.webpadcs-topic-cardadcs-topic-cardhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/China%20Market%20Access%20After%20NRDL%20Maturity-What%20Comes%20After%20the%20Price%20Reset.jpgChina Market Access After NRDL Maturity-What Comes After the Price ResetChina Market Access After NRDL Maturity-What Comes After the Price Resethttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20APAC%20Imperative%20for%20Phase%20III%20Trials.jpgThe APAC Imperative for Phase III TrialsThe APAC Imperative for Phase III Trialshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20Role%20of%20Societal%20Value%20Analyses%20in%20Supporting%20Access%20to%20Novel%20Pharmacotherapies%20in%20Asia-Pacific%20Markets.jpgThe Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific MarketsThe Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific Marketshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/homepage-APAC-card-1.webphomepage-APAC-card-1homepage-APAC-card-12026-06-30https://www.instituteatprecision.com/experts/cynthia-miller2026-06-29https://www.instituteatprecision.com/experts/stephanie-kennedy2026-06-29https://www.instituteatprecision.com/experts/ivan-barrera2026-06-29https://www.instituteatprecision.com/experts/deborah-phippard2026-06-29https://www.instituteatprecision.com/experts/james-cheong2026-06-29https://www.instituteatprecision.com/experts/zhenfei-yin2026-06-29https://www.instituteatprecision.com/experts/jing-ping-yeo2026-06-29https://www.instituteatprecision.com/experts/cherry-moldovan2026-06-29https://www.instituteatprecision.com/experts/kennon-daniels2026-06-29https://www.instituteatprecision.com/experts/ashwin-athri2026-06-29https://www.instituteatprecision.com/experts/kurt-preugschat2026-06-29https://www.instituteatprecision.com/experts/amy-martin2026-06-29https://www.instituteatprecision.com/experts/alex-grosvenor2026-06-29https://www.instituteatprecision.com/experts/eve-jamali2026-06-29https://www.instituteatprecision.com/experts/jason-mcdonough2026-06-29https://www.instituteatprecision.com/experts/courtney-ottoson2026-06-29https://www.instituteatprecision.com/experts/robert-bauer2026-06-29https://www.instituteatprecision.com/antibody-drug-conjugateshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/HEOR%20Value%20demonstration%20for%20Antibody-Drug%20Conjugates_%20Lessons%20learned%20from%20the%20first%2025%20years.jpgHEOR Value demonstration for Antibody-Drug Conjugates_ Lessons learned from the first 25 yearsHEOR Value demonstration for Antibody-Drug Conjugates_ Lessons learned from the first 25 yearshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Nicholas%20Richardson.pngNicholas RichardsonNicholas Richardsonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/ADC-topic-page-card-1.webpADC-topic-page-card-1ADC-topic-page-card-1https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ross%20Maclean.pngRoss MacleanRoss Macleanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Twenty-Five%20Years%20of%20Antibody%E2%80%93Drug%20Conjugates_%20From%20Breakthroughs%20to%20Access%20by%20Design.jpgTwenty-Five Years of Antibody–Drug Conjugates_ From Breakthroughs to Access by DesignTwenty-Five Years of Antibody–Drug Conjugates_ From Breakthroughs to Access by Designhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/The%20ADC%20Pendulum.webpThe ADC PendulumThe ADC Pendulumhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Cherry%20Moldovan.pngCherry MoldovanCherry Moldovanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/ADC-topic-page-card-2.webpADC-topic-page-card-2ADC-topic-page-card-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Hannah%20Deresewicz.pngHannah DeresewiczHannah Deresewiczhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Harpreet%20Singh.pngHarpreet SinghHarpreet Singhhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Greg%20Gregory.pngGreg GregoryGreg Gregoryhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/ADC-topic-page-card-3.webpADC-topic-page-card-3ADC-topic-page-card-3https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ivan%20Barrera.pngIvan BarreraIvan Barrerahttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Asset%20Thumbnails/Moving%20ADCs%20to%20the%20Front%20Line_%20Perspectives%20from%20FDA%20Oncology%20Experts.jpgMoving ADCs to the Front Line_ Perspectives from FDA Oncology ExpertsMoving ADCs to the Front Line_ Perspectives from FDA Oncology Experts2026-06-30https://www.instituteatprecision.com/experts/maureen-hennessey2026-06-29https://www.instituteatprecision.com/insights/societal-value-apachttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/About-page-card-1-gold.svgAbout-page-card-1-goldAbout-page-card-1-goldhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/APAC-NRDL-LP-Card-2.svgAPAC-NRDL-LP-Card-2APAC-NRDL-LP-Card-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/About-page-card-2-gold.svgAbout-page-card-2-goldAbout-page-card-2-gold2026-06-30https://www.instituteatprecision.com/abouthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Videos/IAP%20-%20Sizzle.mp4/medium.jpgIAP - SizzleIAP - Sizzlehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Videos/IAP%20-%20Sizzle.mp4123nonohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ross%20Maclean.pngRoss MacleanRoss Macleanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Harpreet%20Singh.pngHarpreet SinghHarpreet Singhhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jen%20Vance.pngJen VanceJen Vancehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Molly%20Borchartdt.pngMolly BorchartdtMolly Borchartdthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Stephanie%20Kennedy.pngStephanie KennedyStephanie Kennedyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Kyle%20Sarnataro.pngKyle SarnataroKyle Sarnatarohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Greg%20Gregory.pngGreg GregoryGreg Gregoryhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Isabella%20Sergio.pngIsabella SergioIsabella Sergiohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Group%201-1.svgGroup 1-1Group 1-1https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Courtney%20Ottoson.pngCourtney OttosonCourtney Ottosonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Andrew%20Cournoyer.pngAndrew CournoyerAndrew Cournoyerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/About-page-card-2-gold.svgAbout-page-card-2-goldAbout-page-card-2-goldhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Kennon%20Daniels.pngKennon DanielsKennon Danielshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Hannah%20Deresewicz.pngHannah DeresewiczHannah Deresewiczhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Julianna%20Kula.pngJulianna KulaJulianna Kulahttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Andrew%20Dymon.pngAndrew DymonAndrew Dymonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Bob%20Bauer.pngBob BauerBob Bauerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/AQ_GlobalAccess_AlexGrosvenor-2.jpgAQ_GlobalAccess_AlexGrosvenor-2AQ_GlobalAccess_AlexGrosvenor-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jason%20McDonough.pngJason McDonoughJason McDonoughhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jing%20Ping%20Yeo.pngJing Ping YeoJing Ping Yeohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Travis%20Harrison.pngTravis HarrisonTravis Harrisonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ashwin%20Athri.pngAshwin AthriAshwin Athrihttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Lance%20Grady.pngLance GradyLance Gradyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/James%20Cheong%20(1).pngJames Cheong (1)James Cheong (1)https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Angelica%20Norrell.pngAngelica NorrellAngelica Norrellhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Darren%20Davis.pngDarren DavisDarren Davishttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Sean%20Hart.pngSean HartSean Harthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Chloe%20Wang.jpgChloe WangChloe Wanghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Chris%20Terrone.pngChris TerroneChris Terronehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Icons/About-page-card-3-opt-2.svgAbout-page-card-3-opt-2About-page-card-3-opt-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ruby%20Wang.jpgRuby WangRuby Wanghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Maureen%20Hennessey.pngMaureen HennesseyMaureen Hennesseyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Angelina%20Bisconte.pngAngelina BisconteAngelina Biscontehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jeroen%20P%20Jansen.pngJeroen P JansenJeroen P Jansenhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Cynthia%20Miller.pngCynthia MillerCynthia Millerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Geoffrey%20Kannan.pngGeoffrey KannanGeoffrey Kannanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Payal%20Kirkani.pngPayal KirkaniPayal Kirkanihttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Anne%20Marie%20Fields.pngAnne Marie FieldsAnne Marie Fieldshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Cherry%20Moldovan.pngCherry MoldovanCherry Moldovanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Amy%20Martin.pngAmy MartinAmy Martinhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Kurt%20Preugschat.pngKurt PreugschatKurt Preugschathttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Nicholas%20Richardson.pngNicholas RichardsonNicholas Richardsonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Nate%20Wible.pngNate WibleNate Wiblehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Jacki%20Chou.pngJacki ChouJacki Chouhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Eve%20Jamali.pngEve JamaliEve Jamalihttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Deb%20Phippard.pngDeb PhippardDeb Phippardhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/John%20McIntyre.pngJohn McIntyreJohn McIntyrehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ivan%20Barrera.pngIvan BarreraIvan Barrerahttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Zhenfei%20Yin.pngZhenfei YinZhenfei Yinhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Marlon%20Graf.jpgMarlon GrafMarlon Grafhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Lauren%20Westberg.pngLauren WestbergLauren Westberg2026-06-29https://www.instituteatprecision.com/experts/anne-marie-fields2026-06-29https://www.instituteatprecision.com/experts/darren-davis2026-06-29https://www.instituteatprecision.com/experts/marlon-graf2026-06-29https://www.instituteatprecision.com/experts/john-mcintyre2026-06-29https://www.instituteatprecision.com/experts/lauren-westberg2026-06-29https://www.instituteatprecision.com/experts/payal-kikani2026-06-29https://www.instituteatprecision.com/expertshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Hannah%20Deresewicz.pngHannah DeresewiczHannah Deresewiczhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ivan%20Barrera.pngIvan BarreraIvan Barrerahttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jeroen%20P%20Jansen.pngJeroen P JansenJeroen P Jansenhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Zhenfei%20Yin.pngZhenfei YinZhenfei Yinhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ross%20Maclean.pngRoss MacleanRoss Macleanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Courtney%20Ottoson.pngCourtney OttosonCourtney Ottosonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Eve%20Jamali.pngEve JamaliEve Jamalihttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Harpreet%20Singh.pngHarpreet SinghHarpreet Singhhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Travis%20Harrison.pngTravis HarrisonTravis Harrisonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Amy%20Martin.pngAmy MartinAmy Martinhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Darren%20Davis.pngDarren DavisDarren Davishttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Andrew%20Dymon.pngAndrew DymonAndrew Dymonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Sean%20Hart.pngSean HartSean Harthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Julianna%20Kula.pngJulianna KulaJulianna Kulahttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Payal%20Kirkani.pngPayal KirkaniPayal Kirkanihttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Greg%20Gregory.pngGreg GregoryGreg Gregoryhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Kyle%20Sarnataro.pngKyle SarnataroKyle Sarnatarohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/James%20Cheong%20(1).pngJames Cheong (1)James Cheong (1)https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Chris%20Terrone.pngChris TerroneChris Terronehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Kurt%20Preugschat.pngKurt PreugschatKurt Preugschathttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/institute-at-precision.pnginstitute-at-precisioninstitute-at-precisionhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Lance%20Grady.pngLance GradyLance Gradyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jen%20Vance.pngJen VanceJen Vancehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Lauren%20Westberg.pngLauren WestbergLauren Westberghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Nicholas%20Richardson.pngNicholas RichardsonNicholas Richardsonhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-medicine-group.pngprecision-medicine-groupprecision-medicine-grouphttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Chloe%20Wang.jpgChloe WangChloe Wanghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Angelica%20Norrell.pngAngelica NorrellAngelica Norrellhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jason%20McDonough.pngJason McDonoughJason McDonoughhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Nate%20Wible.pngNate WibleNate Wiblehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Cynthia%20Miller.pngCynthia MillerCynthia Millerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-aq.pngprecision-aqprecision-aqhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Cherry%20Moldovan.pngCherry MoldovanCherry Moldovanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Molly%20Borchartdt.pngMolly BorchartdtMolly Borchartdthttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ashwin%20Athri.pngAshwin AthriAshwin Athrihttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Kennon%20Daniels.pngKennon DanielsKennon Danielshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Ruby%20Wang.jpgRuby WangRuby Wanghttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Geoffrey%20Kannan.pngGeoffrey KannanGeoffrey Kannanhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Deb%20Phippard.pngDeb PhippardDeb Phippardhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Stephanie%20Kennedy.pngStephanie KennedyStephanie Kennedyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Bob%20Bauer.pngBob BauerBob Bauerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Andrew%20Cournoyer.pngAndrew CournoyerAndrew Cournoyerhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Jacki%20Chou.pngJacki ChouJacki Chouhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/institute-at-precision-u5/branding/precision-for-medicine.pngprecision-for-medicineprecision-for-medicinehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Angelina%20Bisconte.pngAngelina BisconteAngelina Biscontehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Marlon%20Graf.jpgMarlon GrafMarlon Grafhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Anne%20Marie%20Fields.pngAnne Marie FieldsAnne Marie Fieldshttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Maureen%20Hennessey.pngMaureen HennesseyMaureen Hennesseyhttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Images/experts-alt-content-opt-1.webpexperts-alt-content-opt-1experts-alt-content-opt-1https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/John%20McIntyre.pngJohn McIntyreJohn McIntyrehttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/AQ_GlobalAccess_AlexGrosvenor-2.jpgAQ_GlobalAccess_AlexGrosvenor-2AQ_GlobalAccess_AlexGrosvenor-2https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Isabella%20Sergio.pngIsabella SergioIsabella Sergiohttps://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Institute%20at%20Precision%20Website/Expert%20Headshots/Jing%20Ping%20Yeo.pngJing Ping YeoJing Ping Yeo2026-06-29https://www.instituteatprecision.com/experts/julianna-kula2026-06-29